Jess S. Morgan & Co’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-53,024
Closed -$3.35M 41
2021
Q1
$3.35M Buy
53,024
+1,320
+3% +$82.1K 2.35% 27
2020
Q4
$3.21M Buy
51,704
+10,960
+27% +$674K 2.55% 28
2020
Q3
$2.46M Buy
40,744
+560
+1% +$33.7K 2.45% 28
2020
Q2
$2.36M Sell
40,184
-5,217
-11% -$312K 2.57% 22
2020
Q1
$2.53M Buy
45,401
+18,165
+67% +$1.11M 3.29% 13
2019
Q4
$1.75M Buy
+27,236
New +$1.56M 1.71% 32

Other funds holding BMY

Jess S. Morgan & Co's BMY Position: Q2 2021 in Review

Jess S. Morgan & Co sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 53,024 shares — an estimated $3.35M sold.

Jess S. Morgan & Co first reported a position in BMY in Q4 2019 and held it in 6 quarters. The position peaked at $3.35M in Q1 2021. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

  • Jess S. Morgan & Co reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
  • Jess S. Morgan & Co sold 53,024 Bristol-Myers Squibb shares in Q2 2021, an estimated $3.35M.
  • Jess S. Morgan & Co first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 6 quarters.
  • Jess S. Morgan & Co's Bristol-Myers Squibb position peaked at $3.35M in Q1 2021.
  • 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Jess S. Morgan & Co's 13F filing for Q2 2021, filed 30 Nov 2021.